| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/18/2011 | EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 05/18/2011 | EP2322185A2 Polynucleotide therapy |
| 05/18/2011 | EP2321334A1 New no releasing steroids derivatives |
| 05/18/2011 | EP1799715B1 Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 05/18/2011 | CN102066323A Novel estrogen receptor ligands |
| 05/18/2011 | CN102060888A Novel compounds |
| 05/18/2011 | CN102058888A Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof |
| 05/18/2011 | CN102058798A Reduction and correction insulin supplementing pills |
| 05/18/2011 | CN102058604A Drug composition containing dienogest and estradiol valerate and preparation method thereof |
| 05/18/2011 | CN101485632B Nimodipine lipid microsphere injection and preparation method thereof |
| 05/18/2011 | CN101045048B Application of chondriosome nutrient composition |
| 05/17/2011 | US7943645 Piperidine compounds for use as orexin receptor antagonist |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
| 05/17/2011 | US7943575 Sustained release drug formulations containing a carrier peptide |
| 05/17/2011 | US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943332 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 05/17/2011 | CA2494574C 7-phenylpyrazolopyridine compounds |
| 05/17/2011 | CA2440726C Substituted benzofuran-2-carboxamides derivatives |
| 05/17/2011 | CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/17/2011 | CA2401385C Protein matrix materials, devices and methods of making and using thereof |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/12/2011 | WO2011056390A2 Method of making an artificial micro-gland that is anisotropic |
| 05/12/2011 | WO2011056389A2 Method of making an artificial micro-gland using taxis |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011034834A3 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 05/12/2011 | WO2011005969A3 Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/12/2011 | US20110112082 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 05/12/2011 | US20110112055 Compositions and methods for treating colitis |
| 05/12/2011 | US20110112020 MEASUREMENT OF G-PROTEIN mRNA IN THE DIAGNOSIS OF GROWTH HORMONE INSUFFICIENCY |
| 05/12/2011 | US20110112015 Use of glis3 for preparing functional pancreatic beta-cells |
| 05/12/2011 | US20110112010 Octanoic acid formulations and methods of treatment using the same |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | CA2773353A1 Oligomer-calcimimetic conjugates and related compounds |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319859A2 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/11/2011 | EP2319841A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319835A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 05/11/2011 | EP2319826A1 Succinate salt of O-desmethyl-venlafaxin |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2318427A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 05/11/2011 | EP2317979A2 Pharmaceutical compositions of somatotrophic hormones |
| 05/11/2011 | EP2317975A1 Octreotide implant having a release agent |
| 05/11/2011 | CN102056939A Restoration of estrogen receptor-alpha activity |
| 05/11/2011 | CN102056897A Sulfonamide compound and application thereof |
| 05/11/2011 | CN102051322A Jujube mixed liquor and production technology thereof |
| 05/11/2011 | CN102050717A Dysideavillosa element A, element B and element C as well as preparation method and application thereof in preparation of drugs |
| 05/11/2011 | CN102049012A Traditional Chinese medicine composition for treating sexual precocity of children and preparation and quality detection method thereof |
| 05/11/2011 | CN102048725A Taxol-cholesterin complex |
| 05/11/2011 | CN102048689A Bioadhesive drug delivery system |
| 05/10/2011 | US7939625 Somatostatin analogues |
| 05/10/2011 | US7939494 Method for administering GLP-1 molecules |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2431890C Lipid microparticles by cryogenic micronization |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/10/2011 | CA2387576C Immuno-interactive fragments of the .alpha.c subunit of inhibin |
| 05/05/2011 | WO2011053821A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | WO2011050742A1 New crystalline forms of agomelatine and preparation methods thereof |
| 05/05/2011 | US20110105551 Analgesics for nasal administration |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105523 Bifeprunox derivatives |
| 05/05/2011 | US20110105482 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders |
| 05/05/2011 | US20110105398 Recombinant fsh including alpha 2,3- and alpha 2,6-sailylatio |
| 05/05/2011 | US20110105389 Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same |
| 05/05/2011 | US20110104296 Endorphin Therapy Compositions and Methods |
| 05/05/2011 | US20110104245 Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and adhesive resins, for medical application purposes |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | CA2778990A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316442A1 Rapid dissolution formulation of a calcium receptor-active compound |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | CN1956954B Novel androgens |
| 05/04/2011 | CN102046646A C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter |
| 05/04/2011 | CN102046192A Compositions of GnRH related compounds and processes of preparation |
| 05/04/2011 | CN102040599A Pharmaceutical application of bicyclo-(2,2,2) octane pentenyl ester |
| 05/04/2011 | CN102040598A Pharmacy application of 1-aza-bicyclo (2, 2, 2) octane amyl |
| 05/04/2011 | CN102040558A Substituted bicyclo(3,3,1)nonane ether compound and application thereof |
| 05/04/2011 | CN102038917A Medicine for treating thyroid hypofunction |
| 05/04/2011 | CN102038826A Medicament for treating hyperthyroidism |
| 05/04/2011 | CN102038825A Formula of traditional Chinese medicine for treating hyperthyroidism |
| 05/04/2011 | CN102038721A Pinus extract and application thereof |
| 05/04/2011 | CN102038674A Application of hydroxybenzopyrone compound in preparing medicines for preventing and treating fracture and osteoporosis |
| 05/04/2011 | CN101032483B Hydantoin derivative for adjusting estrogen receptor activity and application thereof |
| 05/03/2011 | US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 05/03/2011 | CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 05/03/2011 | CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/03/2011 | CA2467517C Substituted benzoxazoles and analogues as estrogenic agents |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2440091C Prodrugs of anticancer agents employing substituted aromatic acids |
| 05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
| 05/03/2011 | CA2415010C Propane-1,3-dione derivatives useful as gnrh receptor antagonist |
| 05/03/2011 | CA2174961C Desferrioxamine oral delivery system |